Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))

Jelle Evers; Lizza E.L. Hendriks; Katrien De Jaeger; Robin Wijsman; Dirk De Ruysscher; Chris Terhaard; Maurice van der Sangen; Sabine Siesling; Henk Struikmans; Mieke J. Aarts

doi:10.1016/j.lungcan.2021.12.012

Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))

Jelle Evers^*
, Lizza E.L. Hendriks
, Katrien De Jaeger
, Robin Wijsman
, Dirk De Ruysscher
, Chris Terhaard
, Maurice van der Sangen
, Sabine Siesling
, Henk Struikmans
, Mieke J. Aarts

^*Corresponding author for this work

Department of Radiotherapy

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

4 Downloads (Pure)

Abstract

The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Table 1 were included, whereas only the upper row regards ‘RT alone’ and the lower row regards ‘Chemotherapy alone’. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.

Original language	English
Pages (from-to)	107
Number of pages	1
Journal	Lung Cancer
Volume	167
DOIs	https://doi.org/10.1016/j.lungcan.2021.12.012
Publication status	Published - May 2022

Access to Document

10.1016/j.lungcan.2021.12.012Licence: CC BY-NC-ND

1-s2.0-S0169500221006401-mainFinal published version, 231 KBLicence: CC BY-NC-ND

Fingerprint

Dive into the research topics of 'Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))'. Together they form a unique fingerprint.

Cite this

Evers, J., Hendriks, L. E. L., De Jaeger, K., Wijsman, R., De Ruysscher, D., Terhaard, C., van der Sangen, M., Siesling, S., Struikmans, H., & Aarts, M. J. (2022). Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011)). Lung Cancer, 167, 107. https://doi.org/10.1016/j.lungcan.2021.12.012

Evers, Jelle ; Hendriks, Lizza E.L. ; De Jaeger, Katrien et al. / Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019 : A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011)). In: Lung Cancer. 2022 ; Vol. 167. pp. 107.

@article{b486ce4094034177ae07eafbb561be32,

title = "Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))",

abstract = "The authors would like to inform that in the original publication two rows stating {\textquoteleft}RT alone{\textquoteright} in Table 1 were included, whereas only the upper row regards {\textquoteleft}RT alone{\textquoteright} and the lower row regards {\textquoteleft}Chemotherapy alone{\textquoteright}. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.",

author = "Jelle Evers and Hendriks, \{Lizza E.L.\} and \{De Jaeger\}, Katrien and Robin Wijsman and \{De Ruysscher\}, Dirk and Chris Terhaard and \{van der Sangen\}, Maurice and Sabine Siesling and Henk Struikmans and Aarts, \{Mieke J.\}",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2022",

month = may,

doi = "10.1016/j.lungcan.2021.12.012",

language = "English",

volume = "167",

pages = "107",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

Evers, J, Hendriks, LEL, De Jaeger, K, Wijsman, R, De Ruysscher, D, Terhaard, C, van der Sangen, M, Siesling, S, Struikmans, H & Aarts, MJ 2022, 'Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))', Lung Cancer, vol. 167, pp. 107. https://doi.org/10.1016/j.lungcan.2021.12.012

Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011)). / Evers, Jelle; Hendriks, Lizza E.L.; De Jaeger, Katrien et al.
In: Lung Cancer, Vol. 167, 05.2022, p. 107.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019

T2 - A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))

AU - Evers, Jelle

AU - Hendriks, Lizza E.L.

AU - De Jaeger, Katrien

AU - Wijsman, Robin

AU - De Ruysscher, Dirk

AU - Terhaard, Chris

AU - van der Sangen, Maurice

AU - Siesling, Sabine

AU - Struikmans, Henk

AU - Aarts, Mieke J.

PY - 2022/5

Y1 - 2022/5

N2 - The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Table 1 were included, whereas only the upper row regards ‘RT alone’ and the lower row regards ‘Chemotherapy alone’. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.

AB - The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Table 1 were included, whereas only the upper row regards ‘RT alone’ and the lower row regards ‘Chemotherapy alone’. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85121971376

U2 - 10.1016/j.lungcan.2021.12.012

DO - 10.1016/j.lungcan.2021.12.012

M3 - Comment/Letter to the editor

C2 - 34973817

AN - SCOPUS:85121971376

SN - 0169-5002

VL - 167

SP - 107

JO - Lung Cancer

JF - Lung Cancer

ER -

Evers J, Hendriks LEL, De Jaeger K, Wijsman R, De Ruysscher D, Terhaard C et al. Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011)). Lung Cancer. 2022 May;167:107. doi: 10.1016/j.lungcan.2021.12.012

Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this